Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of ...

NHS England has expanded access to the prostate cancer drug abiraterone after patient and charity campaigning. Previously ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, ...

A new American Cancer Society report highlights major improvements in cancer survivorship.About 70% of people in the U.S.

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

Prostate cancer is one of the most common cancers affecting men, and doctors regularly stress how important it is to notice early changes rather than brushing them off. Alongside familiar advice about ...

Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

IsoPSA offers a more precise prostate cancer screening by analyzing PSA protein isoforms, reducing false positives compared to traditional PSA tests. Clinical studies show IsoPSA's superior diagnostic ...